Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients

Christiane Matuschek, Edwin Bölke, Caroline Geigis, Kai Kammers, Ute Ganswindt, Kathrin Scheckenbach, Stephan Gripp, Jannis Simiantonakis, Thomas K. Hoffmann, Jens Greve, Peter Arne Gerber, Klaus Orth, Henning Roeder, Matthias G. Hautmann, Wilfried Budach

Research output: Contribution to journalArticle

Abstract

Purpose/objective(s) Intensification of radiotherapy and chemotherapy for head-and-neck cancer (HNC) may lead to increased rates of long term dysphagia as a severe side effect. Mucositis and consequent swallowing problems require artificial nutrition in many HNC patients undergoing radiotherapy or chemoradiation. It is unknown, which predict factors for prophylactic PEG tube insertion appear useful. Materials/methods From an institutional database, 101 patients (72 male, 29 female, mean age 59.5 years) were identified who underwent radiotherapy or chemoradiation for HNC. Primary end point of the investigation was the need for artificial nutrition for more than 4 days during radiotherapy. Dose volume parameters of defined normal tissue structures potentially of relevance for swallowing ability as well as clinical factors were used to develop a predictive model using a binary multiple logistic regression model. Results Whereas several dosimetric and clinical factors were significant predictors for the need of artificial nutrition on univariate analysis, on multivariate analysis only three factors remained independently significant: mean dose to the oropharynx + 1 cm circumferential margin, ECOG performance state (0–1 vs. 2–4), and the use of chemotherapy (yes vs. no). Conclusions Using a 3 parameter model we could distinguish HNC-patients with different risks for the need of artificial nutrition during radiotherapy. After independent validation, the model could be helpful to decision on prophylactic PEG tube insertion.

Original languageEnglish (US)
Pages (from-to)28-35
Number of pages8
JournalRadiotherapy and Oncology
Volume120
Issue number1
DOIs
StatePublished - Jul 1 2016

Fingerprint

Nutritional Requirements
Head and Neck Neoplasms
Radiotherapy
Deglutition
Logistic Models
Drug Therapy
Mucositis
Oropharynx
Deglutition Disorders
Multivariate Analysis
Databases

Keywords

  • Artificial nutrition
  • Feeding tube
  • Head and neck cancer
  • PEG
  • Radiation therapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients. / Matuschek, Christiane; Bölke, Edwin; Geigis, Caroline; Kammers, Kai; Ganswindt, Ute; Scheckenbach, Kathrin; Gripp, Stephan; Simiantonakis, Jannis; Hoffmann, Thomas K.; Greve, Jens; Gerber, Peter Arne; Orth, Klaus; Roeder, Henning; Hautmann, Matthias G.; Budach, Wilfried.

In: Radiotherapy and Oncology, Vol. 120, No. 1, 01.07.2016, p. 28-35.

Research output: Contribution to journalArticle

Matuschek, C, Bölke, E, Geigis, C, Kammers, K, Ganswindt, U, Scheckenbach, K, Gripp, S, Simiantonakis, J, Hoffmann, TK, Greve, J, Gerber, PA, Orth, K, Roeder, H, Hautmann, MG & Budach, W 2016, 'Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients', Radiotherapy and Oncology, vol. 120, no. 1, pp. 28-35. https://doi.org/10.1016/j.radonc.2016.05.017
Matuschek, Christiane ; Bölke, Edwin ; Geigis, Caroline ; Kammers, Kai ; Ganswindt, Ute ; Scheckenbach, Kathrin ; Gripp, Stephan ; Simiantonakis, Jannis ; Hoffmann, Thomas K. ; Greve, Jens ; Gerber, Peter Arne ; Orth, Klaus ; Roeder, Henning ; Hautmann, Matthias G. ; Budach, Wilfried. / Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients. In: Radiotherapy and Oncology. 2016 ; Vol. 120, No. 1. pp. 28-35.
@article{874b341102cc47bfa58348b67df63177,
title = "Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients",
abstract = "Purpose/objective(s) Intensification of radiotherapy and chemotherapy for head-and-neck cancer (HNC) may lead to increased rates of long term dysphagia as a severe side effect. Mucositis and consequent swallowing problems require artificial nutrition in many HNC patients undergoing radiotherapy or chemoradiation. It is unknown, which predict factors for prophylactic PEG tube insertion appear useful. Materials/methods From an institutional database, 101 patients (72 male, 29 female, mean age 59.5 years) were identified who underwent radiotherapy or chemoradiation for HNC. Primary end point of the investigation was the need for artificial nutrition for more than 4 days during radiotherapy. Dose volume parameters of defined normal tissue structures potentially of relevance for swallowing ability as well as clinical factors were used to develop a predictive model using a binary multiple logistic regression model. Results Whereas several dosimetric and clinical factors were significant predictors for the need of artificial nutrition on univariate analysis, on multivariate analysis only three factors remained independently significant: mean dose to the oropharynx + 1 cm circumferential margin, ECOG performance state (0–1 vs. 2–4), and the use of chemotherapy (yes vs. no). Conclusions Using a 3 parameter model we could distinguish HNC-patients with different risks for the need of artificial nutrition during radiotherapy. After independent validation, the model could be helpful to decision on prophylactic PEG tube insertion.",
keywords = "Artificial nutrition, Feeding tube, Head and neck cancer, PEG, Radiation therapy",
author = "Christiane Matuschek and Edwin B{\"o}lke and Caroline Geigis and Kai Kammers and Ute Ganswindt and Kathrin Scheckenbach and Stephan Gripp and Jannis Simiantonakis and Hoffmann, {Thomas K.} and Jens Greve and Gerber, {Peter Arne} and Klaus Orth and Henning Roeder and Hautmann, {Matthias G.} and Wilfried Budach",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.radonc.2016.05.017",
language = "English (US)",
volume = "120",
pages = "28--35",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients

AU - Matuschek, Christiane

AU - Bölke, Edwin

AU - Geigis, Caroline

AU - Kammers, Kai

AU - Ganswindt, Ute

AU - Scheckenbach, Kathrin

AU - Gripp, Stephan

AU - Simiantonakis, Jannis

AU - Hoffmann, Thomas K.

AU - Greve, Jens

AU - Gerber, Peter Arne

AU - Orth, Klaus

AU - Roeder, Henning

AU - Hautmann, Matthias G.

AU - Budach, Wilfried

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Purpose/objective(s) Intensification of radiotherapy and chemotherapy for head-and-neck cancer (HNC) may lead to increased rates of long term dysphagia as a severe side effect. Mucositis and consequent swallowing problems require artificial nutrition in many HNC patients undergoing radiotherapy or chemoradiation. It is unknown, which predict factors for prophylactic PEG tube insertion appear useful. Materials/methods From an institutional database, 101 patients (72 male, 29 female, mean age 59.5 years) were identified who underwent radiotherapy or chemoradiation for HNC. Primary end point of the investigation was the need for artificial nutrition for more than 4 days during radiotherapy. Dose volume parameters of defined normal tissue structures potentially of relevance for swallowing ability as well as clinical factors were used to develop a predictive model using a binary multiple logistic regression model. Results Whereas several dosimetric and clinical factors were significant predictors for the need of artificial nutrition on univariate analysis, on multivariate analysis only three factors remained independently significant: mean dose to the oropharynx + 1 cm circumferential margin, ECOG performance state (0–1 vs. 2–4), and the use of chemotherapy (yes vs. no). Conclusions Using a 3 parameter model we could distinguish HNC-patients with different risks for the need of artificial nutrition during radiotherapy. After independent validation, the model could be helpful to decision on prophylactic PEG tube insertion.

AB - Purpose/objective(s) Intensification of radiotherapy and chemotherapy for head-and-neck cancer (HNC) may lead to increased rates of long term dysphagia as a severe side effect. Mucositis and consequent swallowing problems require artificial nutrition in many HNC patients undergoing radiotherapy or chemoradiation. It is unknown, which predict factors for prophylactic PEG tube insertion appear useful. Materials/methods From an institutional database, 101 patients (72 male, 29 female, mean age 59.5 years) were identified who underwent radiotherapy or chemoradiation for HNC. Primary end point of the investigation was the need for artificial nutrition for more than 4 days during radiotherapy. Dose volume parameters of defined normal tissue structures potentially of relevance for swallowing ability as well as clinical factors were used to develop a predictive model using a binary multiple logistic regression model. Results Whereas several dosimetric and clinical factors were significant predictors for the need of artificial nutrition on univariate analysis, on multivariate analysis only three factors remained independently significant: mean dose to the oropharynx + 1 cm circumferential margin, ECOG performance state (0–1 vs. 2–4), and the use of chemotherapy (yes vs. no). Conclusions Using a 3 parameter model we could distinguish HNC-patients with different risks for the need of artificial nutrition during radiotherapy. After independent validation, the model could be helpful to decision on prophylactic PEG tube insertion.

KW - Artificial nutrition

KW - Feeding tube

KW - Head and neck cancer

KW - PEG

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84992028999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992028999&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2016.05.017

DO - 10.1016/j.radonc.2016.05.017

M3 - Article

C2 - 27296411

AN - SCOPUS:84992028999

VL - 120

SP - 28

EP - 35

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 1

ER -